GLP-1s and Biosimilars—What to Know About This Trend

Free to International Foundation and ISCEBS members

Thoughtful and strategic decisions are essential to delivering lower costs and helping clients choose the right opportunities at the right time. As market and client needs change, so do strategies. Plan sponsors need to continue to review new products and pricing to update strategies to align with client needs and the changing pharmaceutical landscape. Takeaways include how policy changes and legislative action are affecting market dynamics, how the explosion of GLP-1 drugs as weight-loss aids is affecting the industry, and the growing significance of biosimilars and how to maximize their potential.